DRUG/DEVICE

Prefilled disposable cassette and durable infusion pump with treprostinil injection, for subcutaneous use

ROUTE OF ADMINISTRATION

Subcutaneous

THERAPEUTIC PLATFORM

Remodulin®

TERRITORY

Worldwide

COMMERCIAL PRODUCT

www.remodulin.com

STATUS

FDA Cleared

(Commercially launched U.S. sales in February 2021)